Arkolith/Insider Trading/ONTX/Form 4

Fruchtman Steven M

PRESIDENT, CHIEF EXECUTIVE OFF, DirectorOnconova Therapeutics, Inc. (ONTX) · full profile →Form 4 · filed Feb 9, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 7, 2024Tax withholding(F)9K$0.67$6K60K
Feb 7, 2024Option exercise(M)21K——70K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 7, 2024Option exercise(M)21K—$021K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-003204) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML